Is weight loss-induced muscle mass loss clinically relevant
If the results hold, retatrutide could be submitted to regulators in late 2026 or 2027, with UK availability most likely in 2027 to 2028
About retatrutide Retatrutide is an investigational, once-weekly, triple hormone receptor agonist, which activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
Calcium release from the sarcoplasmic reticulum increases, making each contraction stronger
Fortunately, that doesnt mean youre without optionsyour body already produces GLP-1, and you can support it naturally through key nutrition and lifestyle strategies
It has a great efficacy rate, and it doesnt cause sexual or emotional side effects.24 There are cardiovascular effects to consider, however, which youll need to discuss with a prescribing doctor.25 Dutasteride, topical and oral In a head-to-head study, oral dutasteride was as effective or more effective than finasteride or minoxidil in several measures of hair recovery.26 However, it appears to have similar side effects as oral finasteride, and at a higher rate, to boot.27 Like finasteride, it has a topical counterpart that circumvents these side effects while maintaining good efficacy
